USC researchers have developed a new method to counter emergent mutations of the coronavirus and hasten vaccine development to stop the pathogen responsible for killing thousands of people and ruining the economy.
While the push to get Americans vaccinated continues across the country, preliminary data has emerged that lab-created monoclonal antibodies could be a treatment for COVID-19.
Southeast Asia is the source of 95 percent of global cassava exports, and the detection in 2015 in Cambodia of the potentially harvest-devastating Sri Lankan cassava mosaic virus (SLCMV) raised alarm. By 2016, the disease, which cannot always be detected visually, had spread, showing its potential to become a major threat to the livelihoods of millions of smallholder farming families.
